US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist
  • 30.480
  • +0.980+3.32%
Close Feb 14 16:00 ET
  • 30.500
  • +0.020+0.07%
Post 19:59 ET
3.40BMarket Cap-30.18P/E (TTM)

Viking Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
49.68%150.92M
57.89%46.24M
34.08%36.56M
43.45%34.05M
65.91%34.07M
43.31%100.83M
44.38%29.29M
68.34%27.27M
34.65%23.74M
26.42%20.54M
Selling and administrative expenses
33.11%49.28M
73.64%15.25M
54.97%13.77M
4.70%10.29M
4.63%9.97M
129.64%37.02M
113.96%8.78M
109.72%8.89M
140.23%9.82M
158.24%9.53M
-General and administrative expense
33.11%49.28M
73.64%15.25M
54.97%13.77M
4.70%10.29M
4.63%9.97M
129.64%37.02M
113.96%8.78M
109.72%8.89M
140.23%9.82M
158.24%9.53M
Research and development costs
59.30%101.64M
51.14%30.99M
23.97%22.79M
70.79%23.77M
118.96%24.1M
17.65%63.81M
26.73%20.5M
53.68%18.38M
2.77%13.92M
-12.32%11.01M
Operating profit
-49.68%-150.92M
-57.89%-46.24M
-34.08%-36.56M
-43.45%-34.05M
-65.91%-34.07M
-43.31%-100.83M
-44.38%-29.29M
-68.34%-27.27M
-34.65%-23.74M
-26.42%-20.54M
Net non-operating interest income expense
173.55%40.85M
131.20%10.82M
143.23%11.51M
161.40%11.8M
567.69%6.72M
875.95%14.93M
546.41%4.68M
1,018.44%4.73M
1,773.44%4.52M
608.45%1.01M
Non-operating interest income
172.57%40.94M
130.43%10.84M
143.63%11.53M
159.95%11.82M
552.32%6.75M
845.25%15.02M
542.90%4.71M
951.78%4.73M
--4.55M
571.43%1.03M
Total other finance cost
6.82%94K
-7.69%24K
1,100.00%24K
-43.75%18K
0.00%28K
49.15%88K
225.00%26K
-92.59%2K
113.28%32K
133.33%28K
Other net income (expense)
112K
1K
109K
2K
Gain on sale of security
--112K
--1K
--109K
--2K
----
----
----
----
----
----
Income before tax
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
-42.86%-22.53M
-10.29%-19.23M
-21.29%-19.53M
Income tax
Net income
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
-42.86%-22.53M
-10.29%-19.23M
-21.29%-19.53M
Net income continuous Operations
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
-42.86%-22.53M
-10.29%-19.23M
-21.29%-19.53M
Minority interest income
Net income attributable to the parent company
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
-42.86%-22.53M
-10.29%-19.23M
-21.29%-19.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
-42.86%-22.53M
-10.29%-19.23M
-21.29%-19.53M
Basic earnings per share
-10.99%-1.01
-28.00%-0.32
4.35%-0.22
-5.26%-0.2
-4.00%-0.26
-1.11%-0.91
3.85%-0.25
-9.52%-0.23
17.39%-0.19
-19.05%-0.25
Diluted earnings per share
-10.99%-1.01
-28.00%-0.32
4.35%-0.22
-5.26%-0.2
-4.00%-0.26
-1.11%-0.91
3.85%-0.25
-9.52%-0.23
17.39%-0.19
-19.05%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 49.68%150.92M57.89%46.24M34.08%36.56M43.45%34.05M65.91%34.07M43.31%100.83M44.38%29.29M68.34%27.27M34.65%23.74M26.42%20.54M
Selling and administrative expenses 33.11%49.28M73.64%15.25M54.97%13.77M4.70%10.29M4.63%9.97M129.64%37.02M113.96%8.78M109.72%8.89M140.23%9.82M158.24%9.53M
-General and administrative expense 33.11%49.28M73.64%15.25M54.97%13.77M4.70%10.29M4.63%9.97M129.64%37.02M113.96%8.78M109.72%8.89M140.23%9.82M158.24%9.53M
Research and development costs 59.30%101.64M51.14%30.99M23.97%22.79M70.79%23.77M118.96%24.1M17.65%63.81M26.73%20.5M53.68%18.38M2.77%13.92M-12.32%11.01M
Operating profit -49.68%-150.92M-57.89%-46.24M-34.08%-36.56M-43.45%-34.05M-65.91%-34.07M-43.31%-100.83M-44.38%-29.29M-68.34%-27.27M-34.65%-23.74M-26.42%-20.54M
Net non-operating interest income expense 173.55%40.85M131.20%10.82M143.23%11.51M161.40%11.8M567.69%6.72M875.95%14.93M546.41%4.68M1,018.44%4.73M1,773.44%4.52M608.45%1.01M
Non-operating interest income 172.57%40.94M130.43%10.84M143.63%11.53M159.95%11.82M552.32%6.75M845.25%15.02M542.90%4.71M951.78%4.73M--4.55M571.43%1.03M
Total other finance cost 6.82%94K-7.69%24K1,100.00%24K-43.75%18K0.00%28K49.15%88K225.00%26K-92.59%2K113.28%32K133.33%28K
Other net income (expense) 112K1K109K2K
Gain on sale of security --112K--1K--109K--2K------------------------
Income before tax -28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M-42.86%-22.53M-10.29%-19.23M-21.29%-19.53M
Income tax
Net income -28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M-42.86%-22.53M-10.29%-19.23M-21.29%-19.53M
Net income continuous Operations -28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M-42.86%-22.53M-10.29%-19.23M-21.29%-19.53M
Minority interest income
Net income attributable to the parent company -28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M-42.86%-22.53M-10.29%-19.23M-21.29%-19.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M-42.86%-22.53M-10.29%-19.23M-21.29%-19.53M
Basic earnings per share -10.99%-1.01-28.00%-0.324.35%-0.22-5.26%-0.2-4.00%-0.26-1.11%-0.913.85%-0.25-9.52%-0.2317.39%-0.19-19.05%-0.25
Diluted earnings per share -10.99%-1.01-28.00%-0.324.35%-0.22-5.26%-0.2-4.00%-0.26-1.11%-0.913.85%-0.25-9.52%-0.2317.39%-0.19-19.05%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More